about
The role of infections in autoimmune diseaseMyocarditis related to Campylobacter jejuni infection: a case reportPredicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical ProteinsT cells contribute to disease severity during coxsackievirus B4 infection.Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte culturesBasal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response.Calpain inhibition protects against virus-induced apoptotic myocardial injury.Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.Reovirus induction of and sensitivity to beta interferon in cardiac myocyte cultures correlate with induction of myocarditis and are determined by viral core proteins.Noninvasive assessment of cardiac abnormalities in experimental autoimmune myocarditis by magnetic resonance microscopy imaging in the mouse.Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditisExogenous interleukin-12 protects against lethal infection with coxsackievirus B4.Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.Reversible Cardiomyopathies.Cardiomyopathy is linked to complement activation.Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes.Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responsesAutoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD miceRecent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesRelevance of molecular mimicry in the mediation of infectious myocarditis.Paroxysmal supraventricular tachycardia in an infant with hand, foot, and mouth disease.Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.Myocarditis mimicking an acute coronary syndrome: a case related to Salmonella enteritis.Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis.Acute hemorrhagic leukoencephalomyelitis in a man with viral myocarditis.Myocarditis as systemic disease: new perspectives on pathogenesis.Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.Rethinking Molecular Mimicry in Rheumatic Heart Disease and Autoimmune Myocarditis: Laminin, Collagen IV, CAR, and B1AR as Initial Targets of DiseaseQuantitative analysis of viral RNA in the murine heart and pancreas with different concentration of coxsackievirus B3.IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.
P2860
Q22242631-0D2F0C4B-603C-4EE9-9E8B-BEE43C55AF86Q24794714-6520A08E-3BD0-4620-8BBA-2E1803DBAB52Q28547255-6157A8E6-ACE5-4425-A24B-035414ADCFE3Q33644332-4BAA9AC7-D68A-4D40-9A52-313FD11CF99FQ33825249-CA45DBA1-E0DA-4ECA-8CEE-711A831518B6Q33833988-049436A3-5167-485F-A9AE-6127A7C33F5FQ33834904-EDD230E1-BC79-41ED-92B4-13AF8274E85CQ33982065-BDE9AF63-A05B-40FA-9B8C-8EC61C0ADB3BQ34069681-622959F5-9D67-4178-B7F8-0E411820EC0DQ34371898-721730F7-4711-4D3B-A233-C244AD9131EDQ34992644-99ADC7D3-4867-4EA1-94A1-88B2AC81B603Q35155018-03D21052-A704-4C9F-90FF-E4E05A980C4FQ35483420-8EAB1FEC-D231-45BD-B2E9-D134A84C0F16Q35636735-BCB820E7-F13B-4251-A065-CD43ABCA98C2Q35747543-6AB4AB96-8DDF-43CE-9283-21132B791B78Q35747641-94957712-0105-4946-AA4D-04F3ED221F60Q36278700-CC454B2F-B922-4603-812B-D1AE37100746Q36282160-AACB06CD-F6EA-4EA0-88CD-F50F2B04A827Q36315128-FE5CAC08-E23B-41FC-9505-1C769899A8AFQ37089400-74657796-4F92-496E-A8BE-EA22F0C140DDQ37438934-CDC3C7E2-48A3-437E-8FEB-B391E2542483Q37619855-D7B98C02-E19A-4DD2-BC0D-EEFAB54CC409Q38009304-9C66F6AE-52FB-4E7F-8ECB-0DE79EE58641Q39454584-B8C2E297-3121-421F-8E51-359B31559B51Q40371995-609B8427-F0E6-487B-BC37-DD654105D069Q40616965-0F23DEF2-E2CC-49BA-A2F0-9152FB4EB21BQ41608853-2C454D55-917F-440D-9C39-53D116108C96Q41667002-77D49A65-2A80-4080-B381-6C5D5DEFE9A7Q41738937-6738E316-F350-496B-B979-1D85F156878BQ41752576-C379BB2B-B258-4309-AA2D-293CF5312750Q46890718-86959161-2E5E-45EF-981B-D25BD7916D02Q52938547-F3ADE604-4B81-4DAF-8D9C-18A0730A562D
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The pathogenesis of postinfectious myocarditis.
@en
type
label
The pathogenesis of postinfectious myocarditis.
@en
prefLabel
The pathogenesis of postinfectious myocarditis.
@en
P356
P1476
The pathogenesis of postinfectious myocarditis.
@en
P356
10.1006/CLIN.1996.0146
P433
P577
1996-09-01T00:00:00Z